GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Tuesday, April 30th. Analysts expect GE HealthCare Technologies to post earnings of $0.90 per share for the quarter. GE HealthCare Technologies has set its FY 2024 guidance at 4.200-4.350 EPS and its FY24 guidance at $4.20-$4.35 EPS.Investors interested in registering for the company’s conference call can do so using this link.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The business had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. During the same quarter in the previous year, the firm posted $1.31 earnings per share. GE HealthCare Technologies’s revenue was up 5.3% compared to the same quarter last year. On average, analysts expect GE HealthCare Technologies to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
GE HealthCare Technologies Trading Down 0.2 %
Shares of GEHC stock opened at $84.31 on Tuesday. GE HealthCare Technologies has a 1 year low of $62.35 and a 1 year high of $94.50. The firm’s fifty day simple moving average is $88.76 and its 200 day simple moving average is $78.08. The firm has a market capitalization of $38.47 billion, a P/E ratio of 27.92, a price-to-earnings-growth ratio of 2.94 and a beta of 0.95. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18.
GE HealthCare Technologies Dividend Announcement
Analyst Ratings Changes
GEHC has been the topic of several analyst reports. HSBC started coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price target on the stock. Argus upped their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Evercore ISI upped their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Citigroup upped their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Finally, Mizuho upped their price target on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, April 11th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $95.09.
Get Our Latest Analysis on GE HealthCare Technologies
About GE HealthCare Technologies
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Further Reading
- Five stocks we like better than GE HealthCare Technologies
- What is the S&P/TSX Index?
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- About the Markup Calculator
- Merger or Not, Albertson’s Companies is a Good Buy
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.